Optimal Timing of Administration of Direct-acting Antivirals for Patients with Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation

Michael K. Turgeon, Shimul A. Shah, Aaron M. Delman, Benjamin V. Tran, Vatche G. Agopian, Joel P. Wedd, Joseph F. Magliocca, Ahyoung Kim, Andrew Cameron, Ali Olyaei, Susan L. Orloff, Matthew P. Anderson, Chandrashekhar A. Kubal, Robert M. Cannon, Jayme E. Locke, Mary A. Simpson, Mohamed E. Akoad, Chelsey P. Wongjirad, Juliet Emamaullee, Amika MoroFederico Aucejo, Cyrus A. Feizpour, Parsia A. Vagefi, Mindie H. Nguyen, Carlos O. Esquivel, Kiran Dhanireddy, Vijay Subramanian, Alejandro Chavarriaga, Marwan M. Kazimi, Maia S. Anderson, Christopher J. Sonnenday, Steven C. Kim, David P. Foley, Marwan Abdouljoud, Reena J. Salgia, Dimitrios Moris, Debra L. Sudan, Swaytha R. Ganesh, Abhinav Humar, Majella Doyle, William C. Chapman, Shishir K. Maithel

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Optimal Timing of Administration of Direct-acting Antivirals for Patients with Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences